rs149772375

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_003184.4(TAF2):​c.1655A>T​(p.Tyr552Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00243 in 1,613,806 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0025 ( 14 hom. )

Consequence

TAF2
NM_003184.4 missense

Scores

2
1
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.27

Publications

5 publications found
Variant links:
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]
TAF2 Gene-Disease associations (from GenCC):
  • microcephaly-thin corpus callosum-intellectual disability syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008978754).
BP6
Variant 8-119788818-T-A is Benign according to our data. Variant chr8-119788818-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 436940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF2NM_003184.4 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 26 ENST00000378164.7 NP_003175.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF2ENST00000378164.7 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 26 1 NM_003184.4 ENSP00000367406.2
TAF2ENST00000686879.1 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 27 ENSP00000509206.1
TAF2ENST00000685235.1 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 26 ENSP00000510174.1
TAF2ENST00000688645.1 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 25 ENSP00000509978.1
TAF2ENST00000523904.2 linkc.1541A>T p.Tyr514Phe missense_variant Exon 12 of 25 3 ENSP00000430832.2
TAF2ENST00000690144.1 linkc.1655A>T p.Tyr552Phe missense_variant Exon 13 of 26 ENSP00000510548.1
TAF2ENST00000685202.1 linkn.1655A>T non_coding_transcript_exon_variant Exon 13 of 27 ENSP00000509214.1
TAF2ENST00000685503.1 linkn.*1047A>T non_coding_transcript_exon_variant Exon 13 of 26 ENSP00000509198.1
TAF2ENST00000685663.1 linkn.*1527A>T non_coding_transcript_exon_variant Exon 15 of 28 ENSP00000508988.1
TAF2ENST00000685684.1 linkn.*3122A>T non_coding_transcript_exon_variant Exon 12 of 25 ENSP00000509441.1
TAF2ENST00000685824.1 linkn.*1356A>T non_coding_transcript_exon_variant Exon 11 of 24 ENSP00000510262.1
TAF2ENST00000685876.1 linkn.*1373A>T non_coding_transcript_exon_variant Exon 14 of 27 ENSP00000510493.1
TAF2ENST00000685993.1 linkn.*1470A>T non_coding_transcript_exon_variant Exon 12 of 25 ENSP00000510102.1
TAF2ENST00000686098.1 linkn.*300A>T non_coding_transcript_exon_variant Exon 12 of 25 ENSP00000509102.1
TAF2ENST00000688037.1 linkn.*1074A>T non_coding_transcript_exon_variant Exon 10 of 23 ENSP00000510169.1
TAF2ENST00000689164.1 linkn.*300A>T non_coding_transcript_exon_variant Exon 11 of 24 ENSP00000508729.1
TAF2ENST00000689919.1 linkn.*1373A>T non_coding_transcript_exon_variant Exon 14 of 26 ENSP00000510768.1
TAF2ENST00000690808.1 linkn.*891A>T non_coding_transcript_exon_variant Exon 13 of 26 ENSP00000509791.1
TAF2ENST00000690922.1 linkn.*67A>T non_coding_transcript_exon_variant Exon 13 of 26 ENSP00000509498.1
TAF2ENST00000691847.1 linkn.*956A>T non_coding_transcript_exon_variant Exon 12 of 24 ENSP00000509663.1
TAF2ENST00000691880.1 linkn.*1311A>T non_coding_transcript_exon_variant Exon 12 of 25 ENSP00000508515.1
TAF2ENST00000692518.1 linkn.*1356A>T non_coding_transcript_exon_variant Exon 11 of 25 ENSP00000508959.1
TAF2ENST00000692707.1 linkn.*1523A>T non_coding_transcript_exon_variant Exon 15 of 28 ENSP00000509024.1
TAF2ENST00000692916.1 linkn.*1042A>T non_coding_transcript_exon_variant Exon 12 of 25 ENSP00000509603.1
TAF2ENST00000685503.1 linkn.*1047A>T 3_prime_UTR_variant Exon 13 of 26 ENSP00000509198.1
TAF2ENST00000685663.1 linkn.*1527A>T 3_prime_UTR_variant Exon 15 of 28 ENSP00000508988.1
TAF2ENST00000685684.1 linkn.*3122A>T 3_prime_UTR_variant Exon 12 of 25 ENSP00000509441.1
TAF2ENST00000685824.1 linkn.*1356A>T 3_prime_UTR_variant Exon 11 of 24 ENSP00000510262.1
TAF2ENST00000685876.1 linkn.*1373A>T 3_prime_UTR_variant Exon 14 of 27 ENSP00000510493.1
TAF2ENST00000685993.1 linkn.*1470A>T 3_prime_UTR_variant Exon 12 of 25 ENSP00000510102.1
TAF2ENST00000686098.1 linkn.*300A>T 3_prime_UTR_variant Exon 12 of 25 ENSP00000509102.1
TAF2ENST00000688037.1 linkn.*1074A>T 3_prime_UTR_variant Exon 10 of 23 ENSP00000510169.1
TAF2ENST00000689164.1 linkn.*300A>T 3_prime_UTR_variant Exon 11 of 24 ENSP00000508729.1
TAF2ENST00000689919.1 linkn.*1373A>T 3_prime_UTR_variant Exon 14 of 26 ENSP00000510768.1
TAF2ENST00000690808.1 linkn.*891A>T 3_prime_UTR_variant Exon 13 of 26 ENSP00000509791.1
TAF2ENST00000690922.1 linkn.*67A>T 3_prime_UTR_variant Exon 13 of 26 ENSP00000509498.1
TAF2ENST00000691847.1 linkn.*956A>T 3_prime_UTR_variant Exon 12 of 24 ENSP00000509663.1
TAF2ENST00000691880.1 linkn.*1311A>T 3_prime_UTR_variant Exon 12 of 25 ENSP00000508515.1
TAF2ENST00000692518.1 linkn.*1356A>T 3_prime_UTR_variant Exon 11 of 25 ENSP00000508959.1
TAF2ENST00000692707.1 linkn.*1523A>T 3_prime_UTR_variant Exon 15 of 28 ENSP00000509024.1
TAF2ENST00000692916.1 linkn.*1042A>T 3_prime_UTR_variant Exon 12 of 25 ENSP00000509603.1

Frequencies

GnomAD3 genomes
AF:
0.00188
AC:
286
AN:
152150
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00254
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00266
AC:
669
AN:
251358
AF XY:
0.00260
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00572
Gnomad ASJ exome
AF:
0.00516
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.00914
GnomAD4 exome
AF:
0.00249
AC:
3634
AN:
1461538
Hom.:
14
Cov.:
30
AF XY:
0.00251
AC XY:
1828
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33474
American (AMR)
AF:
0.00601
AC:
269
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00742
AC:
194
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.000974
AC:
84
AN:
86252
European-Finnish (FIN)
AF:
0.000693
AC:
37
AN:
53416
Middle Eastern (MID)
AF:
0.00642
AC:
37
AN:
5762
European-Non Finnish (NFE)
AF:
0.00250
AC:
2783
AN:
1111742
Other (OTH)
AF:
0.00363
AC:
219
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
179
357
536
714
893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00187
AC:
285
AN:
152268
Hom.:
1
Cov.:
31
AF XY:
0.00167
AC XY:
124
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41580
American (AMR)
AF:
0.00321
AC:
49
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00253
AC:
172
AN:
68018
Other (OTH)
AF:
0.00285
AC:
6
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00240
Hom.:
1
Bravo
AF:
0.00237
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00302
AC:
26
ExAC
AF:
0.00259
AC:
314
Asia WGS
AF:
0.000578
AC:
2
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TAF2: BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Aug 13, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Microcephaly-thin corpus callosum-intellectual disability syndrome Benign:1
Feb 10, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
21
DANN
Benign
0.85
DEOGEN2
Benign
0.0099
T
Eigen
Benign
-0.18
Eigen_PC
Benign
0.062
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0090
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
6.3
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.15
Sift
Benign
0.67
T
Sift4G
Benign
0.68
T
Vest4
0.67
ClinPred
0.026
T
GERP RS
5.6
Varity_R
0.33
gMVP
0.35
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149772375; hg19: chr8-120801058; API